Company · CIK 1718108
Surface Oncology, Inc.
| CIK | 1718108 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-05-29 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-231144 | 2019-05-01 | 2023-09-12 | 4 | |
| 333-258518 | 2021-08-05 | 2023-09-12 | 3 | |
| 333-223877 | 2018-03-23 | 2018-04-20 | 6 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-09-12 | EFFECTDeclared effective | 333-258518 | 9999999995-23-002629 |
| 2023-09-12 | EFFECTDeclared effective | 333-231144 | 9999999995-23-002628 |
| 2021-08-13 | EFFECTDeclared effective | 333-258518 | 9999999995-21-003204 |
| 2021-08-05 | S-3Shelf registered | 333-258518 | 0001193125-21-237921 |
| 2020-05-22 | 424B5Shelf takedown | 333-231144 | 0001193125-20-150086 |
| 2019-05-08 | EFFECTDeclared effective | 333-231144 | 9999999995-19-001053 |
| 2019-05-01 | S-3Shelf registered | 333-231144 | 0001193125-19-130940 |
| 2018-04-20 | 424B4Final prospectus | 333-223877 | 0001193125-18-122977 |
| 2018-04-18 | EFFECTDeclared effective | 333-223877 | 9999999995-18-000852 |
| 2018-04-13 | S-1/AAmendment | 333-223877 | 0001193125-18-116756 |
| 2018-04-09 | S-1/AAmendment | 333-223877 | 0001193125-18-110874 |
| 2018-03-30 | S-1/AAmendment | 333-223877 | 0001193125-18-103331 |
| 2018-03-23 | S-1Registration filed | 333-223877 | 0001193125-18-094098 |
| 2017-11-17 | DRSDraft made public | 377-01795 | 0000950123-17-011042 |